Manufacturing, Biologic Drugs

Lilly and CureVac Partner on mRNA Cancer Vaccines in $1.8-Billion Deal

October 20, 2017

The companies aim to use CureVac’s proprietary messenger RNA technology to develop and commercialize up to five potential cancer vaccine products.

NJII and Rutgers University to Form the New Jersey Continuous Manufacturing Institute

October 18, 2017

The partnership and the formation of the institute intend to bring together industry, academia, and regulators to tackle challenges and provide solutions for continuous manufacturing.

FDA Licenses Second Samsung BioLogics Facility

October 14, 2017

Samsung BioLogics’ second facility adds 152,000 L of mAb drug substance capacity.

Promethera and Shibuya Partner on New Cell-Therapy Manufacturing Platform

October 12, 2017

The companies have entered into a strategic collaboration to establish a new cell therapy and regenerative medicine manufacturing platform, which includes a new manufacturing facility in Belgium.

Sanofi to Expand Influenza Vaccine Production Facility

October 12, 2017

The company is investing EUR 170 million (US$201 million) to expand its vaccine manufacturing site in France for its newest influenza vaccine.

J&J Invests in Biologic Manufacturing Capacity Expansion in Ireland

October 11, 2017

Johnson & Johnson’s Janssen Sciences Ireland UC will invest more than EUR 300 million (US$355 million) to expand manufacturing capacity for biologic medicines at its Ireland facility.

ProBioGen and Chiome in Antibody Manufacturing Deal

October 06, 2017

Under an agreement, ProBioGen will develop a stable cell-line for and manufacture an anti-cancer antibody for Chiome using its proprietary cancer cell-killing technology.

BARDA Funds Ebola Vaccine and Drug Development

October 04, 2017

Under Project BioShield, the agency could provide more than $170 million in funding to purchase and support late-stage development of Ebola vaccines and therapeutic drugs.

GE Healthcare Opens 3D-Printing Lab, Prints Equipment for Biomanufacturing

October 03, 2017

GE Healthcare opened a 3D printing lab in Sweden that will speed the launch of products for bio/pharma manufacturing, such as a custom chromatography column.

Testing and Simulation Approaches for Single-Use Bioreactor Scale-up

October 02, 2017

Tools aid scale-up and comparison of single-use and stainless-steel bioreactors.